Evidence map›Paper›PMID 31226171›Full record

ArticlePLoS pathogens2019

The lectin-specific activity of Toxoplasma gondii microneme proteins 1 and 4 binds Toll-like receptor 2 and 4 N-glycans to regulate innate immune priming.

Aline Sardinha-Silva, Flávia C Mendonça-Natividade, Camila F Pinzan, Carla D Lopes, Diego L Costa, Damien Jacot, Fabricio F Fernandes, André L V Zorzetto-Fernandes, Nicholas J Gay, Alan Sher and 4 more

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 1 pooled it
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 1 synthesis or guideline pooled it, 50 citations in OpenAlex.

  1. Pooled it
  2. HarnessingAnnals of medicine · 2026
    Review
  3. Article
  4. Review
  5. Recombinant Microneme Proteins MIC1 and MIC4 fromPathogens (Basel, Switzerland) · 2025
    Article
  6. Establishment of an ELISA for detecting oocyst-derivedFrontiers in veterinary science · 2025
    Article
  7. Article
  8. Review
  9. Construction and biological function ofZhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences · 2024
    Article
  10. Article
  11. Review
  12. Article
  13. Vaccines · 2024
    Article
  14. Article
  15. Article
  16. Article
  17. Mining the Proteome ofAnimals : an open access journal from MDPI · 2022
    Review
  18. Review
  19. Dominique Soldati-Favre: BringingFrontiers in cellular and infection microbiology · 2022
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 4 countries.

Aline Sardinha-SilvaDepartment of Cell and Molecular Biology and Pathogenic Bioagents, Ribeirao Preto Medical School, University of Sao Paulo- USP (FMRP/USP), Ribeirao Preto, Sao Paulo, Brazil.
Flávia C Mendonça-NatividadeDepartment of Cell and Molecular Biology and Pathogenic Bioagents, Ribeirao Preto Medical School, University of Sao Paulo- USP (FMRP/USP), Ribeirao Preto, Sao Paulo, Brazil.
Camila F PinzanDepartment of Cell and Molecular Biology and Pathogenic Bioagents, Ribeirao Preto Medical School, University of Sao Paulo- USP (FMRP/USP), Ribeirao Preto, Sao Paulo, Brazil.
Carla D LopesDepartment of Cell and Molecular Biology and Pathogenic Bioagents, Ribeirao Preto Medical School, University of Sao Paulo- USP (FMRP/USP), Ribeirao Preto, Sao Paulo, Brazil.
Diego L CostaLaboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States of America.ORCID 0000-0002-9440-2814
Damien JacotDepartment of Microbiology and Molecular Medicine, CMU, University of Geneva, Switzerland.
Fabricio F FernandesDepartment of Cell and Molecular Biology and Pathogenic Bioagents, Ribeirao Preto Medical School, University of Sao Paulo- USP (FMRP/USP), Ribeirao Preto, Sao Paulo, Brazil.
André L V Zorzetto-FernandesDepartment of Cell and Molecular Biology and Pathogenic Bioagents, Ribeirao Preto Medical School, University of Sao Paulo- USP (FMRP/USP), Ribeirao Preto, Sao Paulo, Brazil.
Nicholas J GayDepartment of Biochemistry, Cambridge University, United Kingdom.ORCID 0000-0002-2782-7169
Alan SherLaboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States of America.ORCID 0000-0001-7053-2895
Dragana JankovicLaboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States of America.ORCID 0000-0001-7360-1809
Dominique Soldati-FavreDepartment of Microbiology and Molecular Medicine, CMU, University of Geneva, Switzerland.
Michael E GriggLaboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States of America.ORCID 0000-0003-3465-3782
Maria Cristina Roque-BarreiraDepartment of Cell and Molecular Biology and Pathogenic Bioagents, Ribeirao Preto Medical School, University of Sao Paulo- USP (FMRP/USP), Ribeirao Preto, Sao Paulo, Brazil.ORCID 0000-0001-7425-0908
Universidade de São Paulo · BRNational Institutes of Health · USUniversity of Geneva · CHUniversity of Cambridge · GB

Funding

Structural Basis of Immune Recognition of Glycosylated AntigensU54GM062116 · NIGMS · SCRIPPS RESEARCH INSTITUTE, THE · PI SASISEKHARAN, RAM · 2001 to 2010
$80.3M
Toxoplasma Surface Antigens and ImmunityZIAAI001017 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI GRIGG, MICHAEL · 2009 to 2025
$9.9M
Medical Research Council G1000133Medical Research Council MR/S002340/1NIGMS NIH HHS U54 GM062116Wellcome TrustWellcome Trust WT100321/Z/12/Z
6 · The paper itself

Abstract

Infection of host cells by Toxoplasma gondii is an active process, which is regulated by secretion of microneme (MICs) and rhoptry proteins (ROPs and RONs) from specialized organelles in the apical pole of the parasite. MIC1, MIC4 and MIC6 assemble into an adhesin complex secreted on the parasite surface that functions to promote infection competency. MIC1 and MIC4 are known to bind terminal sialic acid residues and galactose residues, respectively and to induce IL-12 production from splenocytes. Here we show that rMIC1- and rMIC4-stimulated dendritic cells and macrophages produce proinflammatory cytokines, and they do so by engaging TLR2 and TLR4. This process depends on sugar recognition, since point mutations in the carbohydrate-recognition domains (CRD) of rMIC1 and rMIC4 inhibit innate immune cells activation. HEK cells transfected with TLR2 glycomutants were selectively unresponsive to MICs. Following in vitro infection, parasites lacking MIC1 or MIC4, as well as expressing MIC proteins with point mutations in their CRD, failed to induce wild-type (WT) levels of IL-12 secretion by innate immune cells. However, only MIC1 was shown to impact systemic levels of IL-12 and IFN-γ in vivo. Together, our data show that MIC1 and MIC4 interact physically with TLR2 and TLR4 N-glycans to trigger IL-12 responses, and MIC1 is playing a significant role in vivo by altering T. gondii infection competency and murine pathogenesis.

Indexed as

Immunity, InnateAnimalsCell Adhesion MoleculesDendritic CellsInterleukin-12MacrophagesMiceMice, KnockoutProtozoan ProteinsSialic AcidsToll-Like Receptor 2Toll-Like Receptor 4ToxoplasmaToxoplasmosis, AnimalCell Adhesion MoleculesInterleukin-12MIC1 protein, Toxoplasma gondiiMIC4 protein, Toxoplasma gondiiMIC6 protein, Toxoplasma gondiiProtozoan ProteinsSialic AcidsTlr2 protein, mouseTlr4 protein, mouseToll-Like Receptor 2Toll-Like Receptor 4

Identifiers

PMID31226171
PMCPMC6608980
OpenAlexW2950122738

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.